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Abstract
Dipyrromethene diﬂuoride-cholesterol (TopFluor-Cholesterol, TF-Chol) is
a widely used cholesterol analogue due to its excellent ﬂuorescence
properties and considerable similarity with natural cholesterol in terms
of membrane partitioning. However, the suitability of TF-Chol for detect-
ing lysosomal cholesterol deposition has recently been questioned. Here,
we highlight the fact that the method of lipid delivery and the anal-
ysis of time-point both affect the membrane distribution and labeling
pattern of TF-Chol, similarly as with radiolabeled cholesterol. Lysoso-
mal sterol accumulation characteristic to a lysosomal storage disease is
most readily detected when the probe is introduced via the physiological
route, i.e. as a sterol fatty acid ester in low-density lipoprotein particles.
When administered to cells from solvent, lysosomal sterol sequestration
becomes evident after an overnight equilibration between membranes.
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Recent advances in fluorescence microscopic techniques
have sparked interest toward fluorescent lipid analogues
that enable visualization of lipid distribution and traf-
ficking in intact cells. These approaches are challenged
by the fact that conjugation of fluorescent moieties tends
to perturb lipid properties. This feature is highlighted in
cholesterol, a small, hydrophobic and planar molecule.
Cholesterol participates in the lateral ordering of themem-
brane, and even minor changes in its structure have been
shown to alter this propensity (1,2). In this regard, any
fluorescent sterol analogue is unlikely to exhibit identical
propertieswith natural cholesterol. Yet, desirable analogues
would be ones that minimally perturb the behavior of the
sterol and surrounding molecules and that can be sensi-
tively detected.
One such probe now widely used is a dipyrromethene
difluoride (BODIPY)-labeled sterol analogue
(TopFluor-Cholesterol, TF-Chol), originally designed
by the group of Robert Bittman (3). TF-Chol has a BOD-
IPY moiety linked to carbon-24 of the sterol side chain.
Similarly to natural cholesterol, it partitions into ordered
domains both in model and cell membranes (3–5). How-
ever, despite the proposed value of the probe, its suitability
to trace cellular cholesterol deposition, in particular within
lysosomes, has recently been questioned (5). At present,
the most commonly used method of delivering TF-Chol
(and other sterol analogues) to cells is by dissolving in
solvent and adding directly to the growth medium. With
this approach, the sterol diffuses to cells from solvent,
equilibrating slowly with intracellular membranes. This
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process is complicated by the fact that hydrophobic sterols
such as TF-Chol have the propensity to aggregate in an
aqueous environment (4,5).
A traditional test case for the cellular partitioning of choles-
terol analogues has been Niemann–Pick type C (NPC),
a lysosomal storage disorder that results in the accumu-
lation of cholesterol in late endosomal compartments (6).
Thus, visualization of the lysosomal cholesterol deposition
of NPC cells has become one of the standard experiments
to test how physiologically sterol analogues behave in cells.
In 4 h upon administration from solvent, TF-Chol can be
visualized on the plasma membrane and diffusely in intra-
cellular membranes (Figure 1A). At this time-point, the
probe does not yet show appreciable lysosomal seques-
tration in either control or NPC cells, as evidenced by
colocalization analysis of TF-Chol with lysosomal dex-
tran (5) (Figure 1A, C). To visualize TF-Chol accumula-
tion in lysosomes with this labeling method, it is advisable
to use incubation times of 18 h or longer (4) (Figure 1B,
C). This is in line with studies on radiolabeled cholesterol:
when delivered directly from the medium to NPC cells,
the equilibration of [3H]-cholesterol between the plasma
membrane and lysosomal pools has an apparent half-time
of 35 h (7).
Major differences in the behavior of TF-Chol and radiola-
beled cholesterol in cells are increased efflux and decreased
esterification of TF-Chol compared to [3H]-cholesterol
(4). The BODIPY moiety of TF-Chol has a slight disorder-
ing effect in disordered membrane domains, enhancing
probe protrusion modes and likely contributing to sterol
efflux at the expense of esterification. As TF-Chol is
readily effluxed from cells (4), prolonged incubation in
the presence of efflux acceptors may significantly reduce
the signal intensity. Therefore, it is preferable to use
lipoprotein-deprived serum during labeling from solvent
carriers to reduce back-exchange of the probe. Otherwise,
one has to use a higher concentration of TF-Chol, which
increases its aggregation tendency (5).
TF-Chol can also be delivered to cells from artificial or
natural hydrophilic carriers.The probe can be readily com-
plexedwith beta-cyclodextrin to perform short (e.g. 2min)
pulse labeling of the plasma membrane (4). This label-
ing method yields robust and uniform plasma membrane
signal (at the level of light microscopy), compared to the
slower and more asynchronous partitioning from solvent
carriers. In terms of detecting lysosomal sterol deposition,
the most physiological method to introduce TF-Chol to
cells is to incorporate it as a fatty acyl ester into low-density
lipoprotein (LDL) particles (8). In NPC cells, the hallmark
is the inability of cells to transport LDL-derived choles-
terol out of late endosomal compartments, even though
any cholesterol – also that added to the plasma mem-
brane or endogenously synthesized – eventually becomes
sequestered in the cholesterol-laden endo/lysosomes (6).
Deposition of LDL-derived TF-Chol in the lysosomes of
NPC-deficient cells is already evident upon 2 h of label-
ing, as this delivery route directly targets the compart-
ment of the NPC defect (8). Upon lysosomal delivery,
TF-Chol ester is, similar to natural cholesterol, hydrolyzed
by acid lipase and transported to cellular membranes in an
NPC1-dependent manner (8).
In summary, both the method of lipid delivery and the
analysis of time-point affect lipid partitioning in cellular
membranes. In the case of TF-Chol, lysosomal accumula-
tion characteristic to NPC disease is most readily detected
when the probe is introduced via the physiological route,
Figure 1: Time-dependent partitioning of TF-Chol in the lysosomes of human primary ﬁbroblasts. NPC1-deﬁcient
GM3123 ﬁbroblasts (obtained from Coriell cell repository) were incubated with Rhodamine-dextran overnight to label terminal endocytic
compartments, followed by incubation with (A) 5 μg/mL (8.7 μM) TF-Chol in normal growth medium containing 5% fetal calf serum for
4 h (as in Ref. 5), or (B) 0.5 μM TF-Chol in medium containing 5% lipoprotein-starved serum for 23 h (as in Ref. 6). Cells were imaged
post-ﬁxation with a Nikon Eclipse Ti-E Inverted Microscope (Nikon). Boxed areas are shown with higher magniﬁcation, scale bars
20 μm. C) Colocalization of TF-Chol and dextran in control (ctrl) or NPC1-deﬁcient (NPC1−/−) cells was quantiﬁed from micrographs
by using Pearson’s correlation coefﬁcient (PCC) (as in Ref. 5, values of 0 and 1 depict low and high colocalization, respectively).
ΔPCC demonstrates the difference in the correlation coefﬁcient in control versus NPC1-deﬁcient cells (values >0 depict an increase in
colocalization). Error bars: SEM (N of cells: 5–9).
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i.e. as a sterol fatty acid ester in LDL particles. When
administered to cells from solvent, lysosomal deposition
becomes evident after an overnight equilibration between
membranes.
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